Get started
Author

Dhruv Ahuja

Comparative Safety of JAK Inhibitors vs TNF Antagonists in Immune-Mediated Inflammatory Diseases
2025 · Virginia Solitano, Dhruv Ahuja, et al. · JAMA Network Open · 36
PDF
Comparative Speed of Early Symptomatic Remission With Advanced Therapies for Moderate-to-Severe Ulcerative Colitis: A Systematic Review and Network Meta-Analysis
2023 · Dhruv Ahuja, Mohammad Hassan Murad, et al. · The American Journal of Gastroenterology · 33
Impact of Treatment Response on Risk of Serious Infections in Patients With Crohn’s Disease: Secondary Analysis of the PYRAMID Registry
2024 · Dhruv Ahuja, Jiyu Luo, et al. · Clinical Gastroenterology and Hepatology · 17
Comparative efficacy trials in inflammatory bowel disease: current and future implications for practice
2022 · Dhruv Ahuja, Siddharth Singh · Current Opinion in Gastroenterology · 12
No Impact of Concomitant Medications on Efficacy and Safety of Biologics and Small Molecules for Ulcerative Colitis
2024 · Dhruv Ahuja, Guangyong Zou, et al. · Clinical Gastroenterology and Hepatology · 8
Comparative Safety of Advanced Therapies for Crohn Disease
2026 · Soo-kyung Park, Dhruv Ahuja, et al. · JAMA Network Open · 3
PDF
Treatment and Outcomes of Crohn’s Disease and Ulcerative Colitis in Newly Diagnosed Adults in the United States, 2007 to 2023
2026 · Dhruv Ahuja, Soo-Kyung Park, et al. · Clinical Gastroenterology and Hepatology · 2
PDF
Impact of Age on Efficacy and Safety of Advanced Therapies During Induction in Ulcerative Colitis: An Individual Patient Data Pooled Analysis from Randomized Controlled Trials
2026 · Dhruv Ahuja, Jaeyoun Choi, et al. · Digestive Diseases and Sciences · 1
Validation of the Modified Multiplier of SES-CD (MM-SES-CD) to Predict Endoscopic Healing in Crohn’s Disease: A Post Hoc Analysis of the SEAVUE Trial
2025 · Dhruv Ahuja, Sama Anvari, et al. · Inflammatory Bowel Diseases · 1
Comparative Risk of Serious Infections With Biologic Agents and Oral Small Molecules in Inflammatory Bowel Diseases: 2026 Update
2026 · Virginia Solitano, Anna Silverman, et al. · Gastroenterology
PDF
Upadacitinib Is Associated with the Lowest Risk of Treatment Failure Among Advanced Therapies for Ulcerative Colitis: A Real-World Administrative Claims Study
2026 · Marianne Hupé, Dhruv Ahuja, et al. · Clinical Gastroenterology and Hepatology
Cancer Risk With Advanced Therapies in Patients With Inflammatory Bowel Diseases: An Administrative Claims–Based Study
2026 · Dhruv Ahuja, Kuan-Hung Yeh, et al. · Clinical Gastroenterology and Hepatology
PDF
Combining immunomodulators with biologic therapies vs. biologic monotherapy in patients with inflammatory bowel diseases: Target trial emulations
2026 · Anna L. Silverman, Dhruv Ahuja, et al. · Therapeutic Advances in Gastroenterology
Adjunctive GLP1 Receptor Agonists in Patients With Inflammatory Bowel Diseases and Obesity and/or Diabetes: A Target Trial Emulation
2026 · Kuan-Hung Yeh, Dhruv Ahuja, et al. · Clinical Gastroenterology and Hepatology
Mo1520 IMPACT OF PRIOR BOWEL RESECTION ON EFFICACY OF ADVANCED THERAPIES IN CROHN’S DISEASE: AN INDIVIDUAL PATIENT DATA META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
2026 · Sudheer K. Vuyyuru, Shane Goodwin, et al. · Gastrointestinal Endoscopy
Mo1520 IMPACT OF PRIOR BOWEL RESECTION ON EFFICACY OF ADVANCED THERAPIES IN CROHN’S DISEASE: AN INDIVIDUAL PATIENT DATA META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
2026 · Sudheer K. Vuyyuru, Shane Goodwin, et al. · Gastroenterology
Tu1584 CANCER RISK WITH ADVANCED THERAPIES IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES: AN ADMINISTRATIVE CLAIMSBASED STUDY
2026 · Dhruv Ahuja, Kuan-Hung Yeh, et al. · Gastrointestinal Endoscopy
Mo1554 COMPARATIVE EFFECTIVENESS OF ADVANCED THERAPIES FOR PREVENTING PENETRATING COMPLICATIONS IN CROHN’S DISEASE: AN ADMINISTRATIVE CLAIMS-BASED STUDY
2026 · Marianne Hupé, Dhruv Ahuja, et al. · Gastrointestinal Endoscopy
Tu1584 CANCER RISK WITH ADVANCED THERAPIES IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES: AN ADMINISTRATIVE CLAIMSBASED STUDY
2026 · Dhruv Ahuja, Kuan-Hung Yeh, et al. · Gastroenterology
Mo1554 COMPARATIVE EFFECTIVENESS OF ADVANCED THERAPIES FOR PREVENTING PENETRATING COMPLICATIONS IN CROHN’S DISEASE: AN ADMINISTRATIVE CLAIMS-BASED STUDY
2026 · Marianne Hupé, Dhruv Ahuja, et al. · Gastroenterology
36 Impact of Prior Exposure to Advanced Therapy and Timing of Discontinuation on Risk of Serious Infections in Patients With Ibd Starting a New Advanced Therapy
2026 · Virginia Solitano, Dhruv Ahuja, et al. · Gastrointestinal Endoscopy
36 Impact of Prior Exposure to Advanced Therapy and Timing of Discontinuation on Risk of Serious Infections in Patients With Ibd Starting a New Advanced Therapy
2026 · Virginia Solitano, Dhruv Ahuja, et al. · Gastroenterology
S1945 Natural History of Crohn’s Disease and Ulcerative Colitis in Newly Diagnosed Hispanic Adults in the United States: A Population-Based Cohort Study
2025 · Dhruv Ahuja, Yuchen Qi, et al. · The American Journal of Gastroenterology
Tu1849: COMPARATIVE RISK OF VENOUS THROMBOEMBOLISM WITH JAK INHIBITORS VS. TNF ANTAGONISTS IN PATIENTS WITH IMMUNE-MEDIATED INFLAMMATORY DISORDERS: A SYSTEMATIC REVIEW AND META-ANALYSIS
2025 · Ritu Gaikwad, Dhruv Ahuja, et al. · Gastroenterology
Tu1901: LOWER EFFICACY OF TNF ANTAGONISTS IN HISPANIC PATIENTS WITH ULCERATIVE COLITIS: POOLED ANALYSIS OF CLINICAL TRIALS
2025 · Claudia Dziegielewski, Dhruv Ahuja, et al. · Gastroenterology
Works count: 31
Citation count: 113
H-index: 5
I10-index: 4
Year
Topic
Type